CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-15 | PERRY GREGORY D Director | Grant or award | +2,450 | 13,344 | ||
| 2025-06-15 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2024-06-11 | PERRY GREGORY D Director | Grant or award | +1,400 | 10,894 | ||
| 2024-06-11 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +3,150 | 3,150 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award | +5,856 | 8,394 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award | +1,100 | 9,494 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +7,808 | 7,808 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-05-31 | PERRY GREGORY D Director | Grant or award | +1,738 | 2,538 | ||
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −518 | 0 | ||
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −420 | 0 | ||
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −800 | 0 |
Page 1 of 1 · 12 trades